论文部分内容阅读
常规化疗不能有效防治恶性肿瘤的淋巴道转移。将化疗药物与各种亲淋巴药物载体结合 ,构成淋巴靶向给药系统 ,经多种途径给药 ,可以杀灭淋巴结中的转移肿瘤细胞 ,具有选择性强、疗效好、毒副作用低的特点。动物实验和临床试验均表明 ,淋巴靶向化疗能有效地预防和治疗恶性肿瘤的淋巴道转移 ,降低复发率 ,改善预后 ,有着非常广阔的发展前景
Conventional chemotherapy can not effectively prevent the lymphatic metastasis of malignant tumors. Combining chemotherapeutic drugs with various lymphotropic drug carriers to form a lymphatic targeting drug delivery system, which can be administered by various routes, can kill metastatic tumor cells in lymph nodes, and has the characteristics of strong selectivity, good curative effect, and low toxic and side effects. . Animal experiments and clinical trials have shown that lymph-targeted chemotherapy can effectively prevent and treat lymphatic metastases of malignant tumors, reduce the recurrence rate, improve the prognosis, and has very broad prospects for development.